Skip to content

Clinical trials

Recruiting Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Status: Recruiting Clear all

275 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20033
20042
20054
20071
20111
20122
20134
20141
20153
20165
20175
20188
201911
20207
202113
202222
202342
202441
202563
202629

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting275

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
AstraZeneca5
M.D. Anderson Cancer Center5
Massachusetts General Hospital5
Shanghai Chest Hospital5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology5
University Health Network, Toronto5
European Institute of Oncology4
Mayo Clinic4
Assistance Publique - Hôpitaux de Paris3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms275
Carcinoma, Non-Small-Cell Lung49
Breast Neoplasms39
Neoplasms30
Colorectal Neoplasms22
Prostatic Neoplasms21
Stomach Neoplasms20
Ovarian Neoplasms19
Disease18
Head and Neck Neoplasms17

Trials

Showing 1 to 25 of 275. Each trial links to its page on Pharma Observatory.

175 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.